Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIRAPARIB Cause Central nervous system lesion? 19 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Central nervous system lesion have been filed in association with NIRAPARIB (ZEJULA). This represents 0.1% of all adverse event reports for NIRAPARIB.

19
Reports of Central nervous system lesion with NIRAPARIB
0.1%
of all NIRAPARIB reports
0
Deaths
4
Hospitalizations

How Dangerous Is Central nervous system lesion From NIRAPARIB?

Of the 19 reports, 4 (21.1%) required hospitalization, and 1 (5.3%) were considered life-threatening.

Is Central nervous system lesion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does NIRAPARIB Cause?

Nausea (5,794) Fatigue (5,240) Constipation (4,128) Platelet count decreased (4,102) Insomnia (2,861) Blood pressure increased (2,464) Headache (2,383) Off label use (2,213) Vomiting (2,029) Carbohydrate antigen 125 increased (1,868)

What Other Drugs Cause Central nervous system lesion?

FINGOLIMOD (2,416) DIMETHYL (1,152) INTERFERON BETA-1A (978) NATALIZUMAB (627) DALFAMPRIDINE (561) GLATIRAMER (492) TERIFLUNOMIDE (315) ADALIMUMAB (229) OFATUMUMAB (185) RITUXIMAB (151)

Which NIRAPARIB Alternatives Have Lower Central nervous system lesion Risk?

NIRAPARIB vs NIRMATRELVIR\RITONAVIR NIRAPARIB vs NIROGACESTAT NIRAPARIB vs NIROGACESTAT HYDROBROMIDE NIRAPARIB vs NIRSEVIMAB NIRAPARIB vs NIRSEVIMAB-ALIP

Related Pages

NIRAPARIB Full Profile All Central nervous system lesion Reports All Drugs Causing Central nervous system lesion NIRAPARIB Demographics